List of ReveraGen BioPharma patents

List of ReveraGen BioPharma patents

List of TARIS Biomedical patents

List of Chegg Inc. patents

List of Accel Robotics Corp patents

List of companies in Entrenext Ventures's investment portfolio

List of patents in the Content management system (CMS) industry

Patents where

Current Assignee

Name

is

‌

ReveraGen BioPharma

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9649320 Non-hormonal steroid modulators of NF-κB for treatment of disease	Patent 9649320 was granted and assigned to ReveraGen BioPharma on May, 2017 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	9649320	May 16, 2017
	‌ US Patent 11382922 Aqueous oral pharmaceutical suspension compositions	Patent 11382922 was granted and assigned to ReveraGen BioPharma on July, 2022 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	11382922	July 12, 2022
	‌ US Patent 9434758 Non-hormonal steroid modulators of NF-κB for treatment of disease	Patent 9434758 was granted and assigned to ReveraGen BioPharma on September, 2016 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	9434758	September 6, 2016
	‌ US Patent 11471471 Aqueous oral pharmaceutical suspension compositions	Patent 11471471 was granted and assigned to ReveraGen BioPharma on October, 2022 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	11471471	October 18, 2022
	‌ US Patent 9198921 Non-hormonal steroid modulators of NF-κB for treatment of disease	Patent 9198921 was granted and assigned to ReveraGen BioPharma on December, 2015 by the United States Patent and Trademark Office.		‌ ReveraGen BioPharma		United States Patent and Trademark Office	9198921	December 1, 2015
	‌ US Patent 10464967 Non-hormonal steroid modulators of NF-κβ for treatment of disease	Patent 10464967 was granted and assigned to ReveraGen BioPharma on November, 2019 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	10464967	November 5, 2019
	‌ US Patent 10206933 Non-hormonal steroid modulators of NF-kB for treatment of disease	Patent 10206933 was granted and assigned to ReveraGen BioPharma on February, 2019 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	10206933	February 19, 2019
	‌ US Patent 10857161 Non-hormonal steroid modulators of NF-kB for treatment of disease	Patent 10857161 was granted and assigned to ReveraGen BioPharma on December, 2020 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	10857161	December 8, 2020
	‌ US Patent 10799514 Non-hormonal steroid modulators of NF-kappa beta for treatment of disease	Patent 10799514 was granted and assigned to ReveraGen BioPharma on October, 2020 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	10799514	October 13, 2020
	‌ US Patent 10000525 Non-hormonal steroid modulators of NF-κB for treatment of disease	Patent 10000525 was granted and assigned to ReveraGen BioPharma on June, 2018 by the United States Patent and Trademark Office.	‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	10000525	June 19, 2018
	‌ US Patent 9637738 Methods and agents to increase therapeutic dystrophin expression in muscle	Patent 9637738 was granted and assigned to ReveraGen BioPharma on May, 2017 by the United States Patent and Trademark Office.		‌ ReveraGen BioPharma		United States Patent and Trademark Office	9637738	May 2, 2017
	‌ US Patent 11690853 Non-hormonal steroid modulators of NF-κβ for treatment of disease		‌ ReveraGen BioPharma	‌ ReveraGen BioPharma		United States Patent and Trademark Office	11690853	July 4, 2023

12 results

0 selected

12 results

0 selected